[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-402281-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-402281-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prep-clinician-pocket-guide-pocket-guide","PrEP Clinician Pocket Guide - Pocket Guide","","Clinical guidance for paying for and safely delivering HIV prevention with PrEP, including federal and patient assistance pathways for medication coverage and affordability barriers. Details required baseline and ongoing lab work and visit schedules for oral PrEP (Truvada/Descovy) and long-acting injectable PrEP (Apretude), plus when to discuss sexual and drug-use history. Provides clear criteria for when PrEP should not be withheld, and outlines nPEP after recent exposure, including recommended testing, medication regimens, and transition back to PrEP. Includes reference sources and a pocket-guide focus on people who inject drugs.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prep-clinician-pocket-guide-pocket-guide/402281/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prep-clinician-pocket-guide-pocket-guide/402281.png","ImageObject",300,407,{"name":42,"@type":43},"kopisore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-27",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What programs help cover PrEP medication and associated clinic or lab costs?","Question",{"text":63,"@type":64},"The guide lists Ready, Set, PrEP! for eligible uninsured clients, and Advancing Access Patient Assistance for co-pay or patient assistance based on insurance status. It also notes that most insurance plans and Medicaid must cover PrEP under the Affordable Care Act, and some states offer additional assistance programs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What baseline and ongoing tests are required for oral PrEP versus Apretude?",{"text":68,"@type":64},"It provides a table of lab work and schedules. Oral PrEP includes baseline HIV testing and counseling, renal status at baseline and every 12 months, STI screening intervals, lipid screening for Descovy users, hepatitis B/C screens, and pregnancy testing for clients of childbearing potential. Apretude specifies a start visit and defined follow-up intervals for HIV status and other screenings.",{"name":70,"@type":61,"acceptedAnswer":71},"When should clinicians initiate nPEP instead of PrEP?",{"text":72,"@type":64},"The guide defines nPEP as antiretroviral use after a very recent potential HIV exposure to prevent infection. If indicated, it recommends referral for testing (including HIV, STIs, hepatitis B/C, and pregnancy when appropriate) and medication taken daily for 28 days, followed by reassessment and discussion of transition to PrEP.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},402281,1790648644,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":26,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":97,"preview_page_count":4},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Counselors/clinicians should:  \n[https://readysetprep.hiv.gov](https://readysetprep.hiv.gov)[ ](https://readysetprep.hiv.gov)or call: 855-447-8410  \n[https://readysetprep.hiv.gov or call: 855-447-8410](https://readysetprep.hiv.gov or call: 855-447-8410)  \n[https://www.gileadadvancingaccess.com/](https://www.gileadadvancingaccess.com/)  \nfinancial-support/uninsured  \n[https://www.gileadadvancingaccess.com/](https://www.gileadadvancingaccess.com/)[ ](https://www.gileadadvancingaccess.com/)copay-coupon-card  \n[https://www.viivconnect.com/for-providers/](https://www.viivconnect.com/for-providers/)  \nviivconnect-programs/  \nPrEP is covered by most health insurance programs and Medicaid. Under the Affordable Care Act, PrEP must be completely covered by almost  \nall health insurance plans. This includes PrEP, clinic visits, and ongoing lab tests. Some states have PrEP assistance programs too.  \nBelow are federal and patient payment programs to explore:  \nReady, Set, PrEP!  \n» Provides free PrEP medication if the client:  \n• Doesn’t have health insurance coverage for prescription drugs  \n• Has taken an HIV test and received a negative result  \n• Has a prescription for PrEP  \n• Lives in the United States, including tribal lands or territories » Clinic visits and lab tests may vary depending on income  \nFree Truvada and Descovy (if client doesn’t have insurance)» Advancing Access Patient Assistance Program:  \nBUILDING BRIDGES TO REACH PEOPLE WHO INJECT DRUGS WITH THE GOAL OF EMPLOYING PrEP FOR HIV PREVENTION  \nCo-pay assistance forTruvada and Descovy (if client has nongovernment insurance)  \n» Advancing Access: 1-877-505-6986 or access online:  \nAssistance for Apretude: ViiV Connect:  \nPreprescription Assessment and Evaluation  \nART, antiretroviral therapy; MSM, men who have sex with men; SSP, syringe services program; STI, sexually transmitted infection.  \nPaying for PrEP Medication, Lab Work, & Clinic Visits  \n\n| Test | Truvada &\u003Cbr>Descovy\u003Cbr>Oral PrEP | Apretude Long-Acting\u003Cbr>Injectable |\n| --- | --- | --- |\n| HIV Status » HIV test(s)\u003Cbr>» Signs/symptoms of\u003Cbr>acute HIV infection » Counsel about continuing PrEP, adherence, side effects, etc | At start &\u003Cbr>every 3 months | At start,\u003Cbr>at 1 month, then\u003Cbr>every 2 months |\n| Renal (kidney) status | At start &\u003Cbr>every 12 months |  |\n| STI screening (syphilis, gonorrhea, chlamydia) 3-site testing for MSM | At start &\u003Cbr>every 3-6 months | At start & every 2-6 months |\n| Lipid screen\u003Cbr>(cholesterol/\u003Cbr>triglycerides) | Only for persons prescribed Descovy; at start & every 12 months |  |\n| Hepatitis B virus,\u003Cbr>hepatitis C virus screens | At start |  |\n| Pregnancy test | For clients of\u003Cbr>childbearing potential | For clients of\u003Cbr>childbearing potential |\n\nCounselors/clinicians should NOT withhold PrEP from clients who:  \n\n| Have a substance use disorder |\n| --- |\n| Are pregnant or planning to conceive |\n| Are breast/chest feeding |\n| Have mental health disorders of any severity |\n| Experience intimate partner violence |\n| Have unstable housing or limited social support |\n| Have recently had an STI |\n| Have a partner living with HIV who hasan undetectable viral load\u003Cbr>Initiate a discussion of the client’s sexual history and drug use history; identify behaviors that may place the client at greater risk for HIV, and encourage safer drug injection and safer sex practices |\n| Individualize decision-making: make sure the client understands the purpose, benefits, and risks associated with PrEP |\n| Make clear that PrEP efficacy depends on consistently taking a pill daily or injections every other month, as well as the recommended lab work and follow-up care |\n\nRefer for appropriate social and psychological support services as indicated  \nnPEP (nonoccupational  \nPostExposure Prophylaxis) is the use of antiretroviral medications after avery recent potential exposure to HIV, in order to prevent infection.4  \n| Obtain a history of the potential exposure event\u003Cbr>» Does the client know their own","cbCaio2gTEbsVhoJ","https://ap.wps.com/l/cbCaio2gTEbsVhoJ","pdf",1515077,"English","# Paying for PrEP Medication, Lab Work, & Clinic Visits\n## Ready, Set, PrEP! and other assistance programs\n# Preprescription Assessment and Evaluation\n## Lab work needed to start PrEP\n## Ongoing management and follow-up intervals\n# When clinicians should NOT withhold PrEP\n# nPEP (Nonoccupational PostExposure Prophylaxis)\n## Obtaining exposure history and testing\n## Medication regimen and transition to PrEP","[{\"question\":\"What programs help cover PrEP medication and associated clinic or lab costs?\",\"answer\":\"The guide lists Ready, Set, PrEP! for eligible uninsured clients, and Advancing Access Patient Assistance for co-pay or patient assistance based on insurance status. It also notes that most insurance plans and Medicaid must cover PrEP under the Affordable Care Act, and some states offer additional assistance programs.\"},{\"question\":\"What baseline and ongoing tests are required for oral PrEP versus Apretude?\",\"answer\":\"It provides a table of lab work and schedules. Oral PrEP includes baseline HIV testing and counseling, renal status at baseline and every 12 months, STI screening intervals, lipid screening for Descovy users, hepatitis B/C screens, and pregnancy testing for clients of childbearing potential. Apretude specifies a start visit and defined follow-up intervals for HIV status and other screenings.\"},{\"question\":\"When should clinicians initiate nPEP instead of PrEP?\",\"answer\":\"The guide defines nPEP as antiretroviral use after a very recent potential HIV exposure to prevent infection. If indicated, it recommends referral for testing (including HIV, STIs, hepatitis B/C, and pregnancy when appropriate) and medication taken daily for 28 days, followed by reassessment and discussion of transition to PrEP.\"}]","PrEP Clinician Pocket Guide - Pocket Guide | PDF",1790528734]